9.90
price up icon7.03%   0.65
pre-market  Pre-market:  9.52   -0.38   -3.84%
loading

Bicara Therapeutics Inc Stock (BCAX) Forecast

The Bicara Therapeutics Inc (BCAX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $9.90. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCAX Price Target
Average 0.00 (-100.00% Downside)
loading

Is Bicara Therapeutics Inc (BCAX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 39.04 Neutral
STOCH(9,6) 21.96 Neutral
STOCHRSI(14) 17.96 Buy
MACD(12,26) -0.952 Sell
ADX(14) 23.96 Neutral
William %R -73.65 Neutral
CCI(14) -88.95 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
11.78
Sell
11.06
Sell
MA20
12.62
Sell
12.05
Sell
MA50
12.72
Sell
12.80
Sell
MA100
12.91
Sell
14.22
Sell
MA200
14.77
Sell
0.00
Buy
Buy: 1 Sell: 9 Neutral: 0
Summary: Sell
According to our latest analysis, BCAX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on BCAX, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 39.04 indicates that BCAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 21.96 indicates that BCAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 17.96 indicates that BCAX is oversold. This suggests that BCAX price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 23.96 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -88.95 indicates that BCAX is still oversold but not to an extreme extent.

Bicara Therapeutics Inc Stock (BCAX) Year by Year Forecast

$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Cap:     |  Volume (24h):